BCLAF1 and neoplasm: In this work, we demonstrate that BCLAF1 competitively inhibits SPOP-mediated ubiquitination and degradation of PD-L1 by interacting with SPOP to maintain PD-L1 expression, ultimately promoting immune evasion and tumor progression of HCC.